Medicine Description sprycel 50 mg
Sprycel contains the active ingredient dasatinib, which inhibits the enzymes responsible for the growth of cancer cells, thus preventing their proliferation. It is used in the treatment of leukemia or acute lymphocytic leukemia, and in the treatment of acute or chronic myeloid leukemia, especially in cases positive for the Philadelphia chromosome.
What are the ingredients of Sprycel?
Sprycel tablets contain the active ingredient:
Indications for Sprycel
It is used in the following cases:
- Treatment of acute lymphoblastic leukemia (ALL)
- Treatment of chronic or acute myeloid leukemia (CML)
- Helps treat Philadelphia chromosome-positive (Ph+) cancers